Newer drugs for myasthenia gravis; a microphysiologic study of effects.
D000200:Action Potentials / Q000187:drug effects; D000470:Alkaloids / Q000494:pharmacology*; D004558:Electric Stimulation; D005071:Evoked Potentials / Q000187:drug effects; D006146:Guanidines / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects; D009157:Myasthenia Gravis / Q000188:drug therapy*; D009411:Nerve Endings / Q000187:drug effects; D009469:Neuromuscular Junction / Q000187:drug effects; D010946:Plants, Medicinal; D010947:Plants, Toxic; D013696:Temperature; D013742:Tetanus; D014702:Veratrine / Q000494:pharmacology; D014703:Veratrum / Q000494:pharmacology*
D000470:Alkaloids; D006146:Guanidines; D014702:Veratrine